Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

The Novel Role of Yin Yang 1 in the Regulation of Epithelial to Mesenchymal Transition in Cancer Via the Dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry

Volume 16, Issue 3-4, 2011, pp. 211-226
DOI: 10.1615/CritRevOncog.v16.i3-4.50
Get accessGet access

ABSTRACT

The majority of cancers develop genetic and molecular strategies to resist conventional cytotoxic therapies as well as escape from the host’s immune surveillance. These events lead to tumor persistence and spread through activation of the epithelial to mesenchymal transition (EMT) program and metastasis. Expression profiling analysis has revealed various tumor metastasis-inducing and metastasis-suppressing genes that regulate the metastatic process and maintain the microenvironment of the tumor cells. EMT in cancer entails the molecular reprogramming and phenotypic changes that characterize the conversion of immobile cancer epithelial cells to motile mesenchymal cells. A hallmark of EMT is the loss of E-cadherin, the epithelial homotypic adhesion molecule, and gain of mesenchymal markers such as vimentin and fibronectin. The molecular mechanisms underlying the initiation of EMT consist, in part, in the constitutive activation of survival signaling pathways such as the nuclear factor (NF)-κB pathway. The NF-κB pathway has been implicated directly in the regulation of EMT and indirectly through the transcription and expression of several gene products that participate in the EMT cascade, such as Snail, the metastasis-inducer and E-cadherin suppressor transcription factor. In turn, Snail represses the metastasis-suppressor gene product Raf-kinase inhibitor protein (RKIP) that inhibits both the Raf-1/MEK/ERK and NF-κB survival pathways implicated in EMT. Consequently, tumor cells normally exhibit a dysregulated NF-κB/Snail/RKIP circuitry that is intimately involved in the initiation of EMT and maintenance of drug resistance. Additional deregulated gene products in this circuit, such as the metastasis-suppressor phosphatase and tensin homologue (PTEN; repressed by Snail) and the putative-metastasis inducer Yin Yang (YY) 1 (target of NF-κB) also have been associated in the regulation of EMT. We recently have investigated the direct role of YY1 in the regulation of EMT. This review discusses the molecular regulation of EMT in cancer cells through the activity of the dysregulated NF-κB/Snail/ YY1/PTEN/RKIP circuitry. In addition, we propose YY1 as a potential novel prognostic biomarker for EMT and a therapeutic target for both the prevention of metastasis and the reversal of resistance.

CITED BY
  1. Hao Chunfang, Wei Sen, Tong Zhongsheng, Li Shufen, Shi Yehui, Wang Xiaorui, Zhu Zhi-hua, The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro, Tumor Biology, 33, 4, 2012. Crossref

  2. Huang Lin, Dai Ting, Lin Xi, Zhao Xiaohui, Chen Xiuting, Wang Chanjuan, Li Xinghua, Shen Huiyong, Wang Xi, MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells, Biochemical and Biophysical Research Communications, 425, 2, 2012. Crossref

  3. Lin Bi-wen, Jiao Ze-long, Fan Jian-feng, Peng Liang, Li Lei, Zhao Zi-gang, Ding Xiang-yu, Li Heng-jin, Inhibitory Effect of Melanoma Differentiation Associated Gene-7/Interleukin-24 on Invasion In Vitro of Human Melanoma Cancer Cells, Journal of Korean Medical Science, 28, 6, 2013. Crossref

  4. Zaravinos Apostolos, Kanellou Peggy, Lambrou George Ι., Spandidos Demetrios A., Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma, Tumor Biology, 35, 5, 2014. Crossref

  5. Liu Hongyi, Li Peng, Li Bing, Sun Peng, Zhang Jiajin, Wang Baishi, Jia Baoqing, RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224, Tumor Biology, 35, 10, 2014. Crossref

  6. Liu Hongyi, Li Peng, Li Bing, Sun Peng, Zhang Jiajin, Wang Baishi, Jia Baoqing, RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN, Tumor Biology, 35, 12, 2014. Crossref

  7. Epanchintsev Alexey, Shyamsunder Pavithra, Verma Rama S., Lyakhovich Alex, IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism, Molecular Carcinogenesis, 54, 12, 2015. Crossref

  8. Rapozzi Valentina, Della Pietra Emilia, Bonavida Benjamin, Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy, Redox Biology, 6, 2015. Crossref

  9. Jiang Guiyang, Zhang Xiupeng, Zhang Yong, Wang Liang, Fan Chuifeng, Xu Hongtao, Miao Yuan, Wang Enhua, A novel biomarker C6orf106 promotes the malignant progression of breast cancer, Tumor Biology, 36, 10, 2015. Crossref

  10. Zhang Xiupeng, Miao Yuan, Yu Xinmiao, Zhang Yong, Jiang Guiyang, Liu Yang, Yu Juanhan, Han Qiang, Zhao Huanyu, Wang Enhua, C6orf106 enhances NSCLC cell invasion by upregulating vimentin, and downregulating E-cadherin and P120ctn, Tumor Biology, 36, 8, 2015. Crossref

  11. Bonavida Benjamin, Kaufhold Samantha, Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target, Pharmacology & Therapeutics, 150, 2015. Crossref

  12. Liu Hongyi, Li Peng, Li Bing, Sun Peng, Zhang Jiajin, Wang Baishi, Jia Baoqing, RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway, Tumor Biology, 36, 3, 2015. Crossref

  13. Bonavida Benjamin, Garban Hermes, Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics, Redox Biology, 6, 2015. Crossref

  14. Renart Jaime, Carrasco-Ramírez Patricia, Fernández-Muñoz Beatriz, Martín-Villar Ester, Montero Lucía, Yurrita María M., Quintanilla Miguel, , 317, 2015. Crossref

  15. Beketaev Ilimbek, Zhang Yi, Kim Eun Young, Yu Wei, Qian Ling, Wang Jun, Critical role of YY1 in cardiac morphogenesis, Developmental Dynamics, 244, 5, 2015. Crossref

  16. Della Pietra Emilia, Simonella Francesca, Bonavida Benjamin, Xodo Luigi Emilio, Rapozzi Valentina, Repeated sub-optimal photodynamic treatments with pheophorbide a induce an epithelial mesenchymal transition in prostate cancer cells via nitric oxide, Nitric Oxide, 45, 2015. Crossref

  17. Ahmad Aamir, Li Yiwei, Sarkar Fazlul H., The bounty of nature for changing the cancer landscape, Molecular Nutrition & Food Research, 60, 6, 2016. Crossref

  18. Guo X. M., Liu X. P., Chang G. B., Xu L., Bi Y. L., Wang H. Z., Zhang Y., Zhu P. F., Wu Y., Chen G. H., Characterization of theNLRC5promoter in chicken: SNPs, regulatory elements and CpG islands, Animal Genetics, 47, 5, 2016. Crossref

  19. Ye Chunxiang, Shen Zhanlong, Wang Bo, Li Yansen, Li Tao, Yang Yang, Jiang Kewei, Ye Yingjiang, Wang Shan, A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit, Journal of Experimental & Clinical Cancer Research, 35, 1, 2016. Crossref

  20. Pothoulakis Charalabos, Torre-Rojas Monica, Duran-Padilla Marco A., Gevorkian Jonathan, Zoras Odysseas, Chrysos Emmanuel, Chalkiadakis George, Baritaki Stavroula, CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis, International Journal of Cancer, 142, 2, 2018. Crossref

  21. Schiera Gabriella, Di Liegro Carlo, Di Liegro Italia, Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles, International Journal of Molecular Sciences, 18, 12, 2017. Crossref

  22. Shvartsur Anna, Givechian Kevin B., Garban Hermes, Bonavida Benjamin, Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma, Journal of Experimental & Clinical Cancer Research, 36, 1, 2017. Crossref

  23. Bonavida B., Chouaib S., Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance, Annals of Oncology, 28, 3, 2017. Crossref

  24. NAKANISHI ATSUKO, KITAGISHI YASUKO, OGURA YASUNORI, MATSUDA SATORU, The tumor suppressor PTEN interacts with p53 in hereditary cancer, International Journal of Oncology, 44, 6, 2014. Crossref

  25. Soubannier Vincent, Stifani Stefano, NF-κB Signalling in Glioblastoma, Biomedicines, 5, 2, 2017. Crossref

  26. Huang Tonghai, Wang Guangsuo, Yang Lin, Peng Bin, Wen Yuxin, Ding Guanggui, Wang Zheng, MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1, Cancer Biomarkers, 21, 1, 2017. Crossref

  27. Bonavida Benjamin, Nitric Oxide Donors Sensitize Resistant Cancer Cells to Apoptosis Induced by Chemotherapy: Molecular Mechanisms of Sensitization, in Nitric Oxide as a Chemosensitizing Agent, 2017. Crossref

  28. Siletz Anaar, Schnabel Michael, Kniazeva Ekaterina, Schumacher Andrew J., Shin Seungjin, Jeruss Jacqueline S., Shea Lonnie D., Roh Tae-Young, Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models, PLoS ONE, 8, 4, 2013. Crossref

  29. Wang Haiji, Xu Chunyuan, Kong Xiaoli, Li Xiaoyan, Kong Xiangnan, Wang Yu, Ding Xia, Yang Qifeng, Anto Ruby John, Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer, PLoS ONE, 9, 6, 2014. Crossref

  30. Wottrich Stephanie, Kaufhold Samantha, Chrysos Emmanuel, Zoras Odysseas, Baritaki Stavroula, Bonavida Benjamin, Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer, Drug Resistance Updates, 30, 2017. Crossref

  31. Wang Wanxue, Yue Zhenni, Tian Zhengping, Xie Yiran, Zhang Jiamiao, She Yuanping, Yang Bing, Ye Yuan, Yang Yihua, Liu Xuefeng, Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6, PLOS ONE, 13, 2, 2018. Crossref

  32. Fang Ming, Huang Wenlong, Wu Xinchi, Gao Yuan, Ou Jing, Zhang Xiaolan, Li Yanyun, Retracted : MiR‐141‐3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1 , The Anatomical Record, 302, 2, 2019. Crossref

  33. Ba Qian, Li Junyang, Huang Chao, Qiu Hongling, Li Jingquan, Chu Ruiai, Zhang Wei, Xie Dong, Wu Yongning, Wang Hui, Effects of Benzo[ a ]pyrene Exposure on Human Hepatocellular Carcinoma Cell Angiogenesis, Metastasis, and NF- κ B Signaling , Environmental Health Perspectives, 123, 3, 2015. Crossref

  34. Zaravinos Apostolos, Bonavida Benjamin, Chatzaki Ekaterini, Baritaki Stavroula, RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact, Cancers, 10, 9, 2018. Crossref

  35. Gao Dan, Wang Lingling, Zhang Hua, Yan Xiaojie, Yang Jie, Zhou Ruimin, Chang Xinzhong, Sun Yanan, Tian Shanshan, Yao Zhi, Zhang Kai, Liu Zhe, Ma Zhenyi, Spleen tyrosine kinase SYK (L) interacts with YY 1 and coordinately suppresses SNAI 2 transcription in lung cancer cells , The FEBS Journal, 285, 22, 2018. Crossref

  36. Camacho-Moctezuma B., Quevedo-Castillo M., Melendez-Zajgla J., Aquino-Jarquin G., Martinez-Ruiz G.U., YY1 negatively regulates the XAF1 gene expression in prostate cancer, Biochemical and Biophysical Research Communications, 508, 3, 2019. Crossref

  37. Khachigian Levon M., The Yin and Yang of YY1 in tumor growth and suppression, International Journal of Cancer, 143, 3, 2018. Crossref

  38. Sarvagalla Sailu, Kolapalli Srinivasa Prasad, Vallabhapurapu Sivakumar, The Two Sides of YY1 in Cancer: A Friend and a Foe, Frontiers in Oncology, 9, 2019. Crossref

  39. Zhang Chuyi, Zhu Xiaoping, Hua Yifei, Zhao Qian, Wang Kaijing, Zhen Lixiao, Wang Guangxue, Lü Jinhui, Luo An, Cho William C., Lin Xin, Yu Zuoren, YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells, Respiratory Research, 20, 1, 2019. Crossref

  40. Rapozzi Valentina, D’Este Francesca, Xodo Luigi E., Molecular pathways in cancer response to photodynamic therapy, Journal of Porphyrins and Phthalocyanines, 23, 04n05, 2019. Crossref

  41. Özenver Nadire, Efferth Thomas, Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  42. Dariya Begum, Chalikonda Gayathri, Alam Afroz, Nagaraju Ganji Purnachandra, Theranostic role of RKIP in cancer, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  43. Noh Hae Sook, Hah Young-Sool, Ha Ji Hye, Kang Min Young, Zada Sahib, Rha Sun Young, Kang Sang Soo, Kim Hyun Joon, Park Jae-Yong, Byun June-Ho, Hahm Jong Ryeal, Shin Jeong Kyu, Jeong Sang-Ho, Lee Young-Joon, Kim Deok Ryong, Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity, Oncotarget, 7, 4, 2016. Crossref

  44. Wang Yuhao, Bonavida Benjamin, Pleiotropic activities of RKIP in cancer: Role in survival, EMT, chemo-immuno-resistance, and autophagy, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  45. Kashyap Vaishali, Bonavida Benjamin, Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression, Genes & Cancer, 5, 3-4, 2014. Crossref

  46. Liang Sitai, Yadav Mukesh, Vogel Kristine S., Habib Samy L., A novel role of snail in regulating tuberin/AMPK pathways to promote renal fibrosis in the new mouse model of type II diabetes, FASEB BioAdvances, 3, 9, 2021. Crossref

  47. Chen Qun, Wang Wu-Jun, Jia Yun-Xuan, Yuan Hao, Wu Peng-Fei, Ge Wan-Li, Meng Ling-Dong, Huang Xu-Min, Shen Peng, Yang Tao-Yue, Miao Yi, Zhang Jing-Jing, Jiang Kui-Rong, Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review, Cell & Bioscience, 11, 1, 2021. Crossref

  48. Meliala Ian Timothy Sembiring, Hosea Rendy, Kasim Vivi, Wu Shourong, Yin and Yang of YY1 regulation on tumor metabolic reprogramming, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  49. Navasardyan Inesa, Bonavida Benjamin, YY1 is involved in the pathogenesis and malignant properties of human triple-negative breast cancer (TNBC), in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  50. Bonavida Benjamin, The role of YY1 in drug resistant cancer: Involvement of the YY1/PTEN/PP2A/H2Ax/Rad51 axis, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  51. Hill Christopher G, Matyunina Lilya V, Walker DeEtte, Benigno Benedict B, McDonald John F, Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression, BMC Systems Biology, 8, 1, 2014. Crossref

  52. D'Este Francesca, Della Pietra Emilia, Badillo Pazmay Gretta Veronica, Xodo Luigi E., Rapozzi Valentina, Role of nitric oxide in the response to photooxidative stress in prostate cancer cells, Biochemical Pharmacology, 182, 2020. Crossref

  53. Panneerpandian Ponmathi, Rao Divya Bhaskar, Ganesan Kumaresan, Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin, Toxicology in Vitro, 74, 2021. Crossref

  54. Kwiatkowska Dominika, Mazur Ewelina, Reich Adam, YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance, Frontiers in Oncology, 12, 2022. Crossref

  55. Vivarelli Silvia, Falzone Luca, Grillo Caterina Maria, Bonavida Benjamin, Crimi Claudia, La Mantia Ignazio, Libra Massimo, Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer, Cancers, 14, 4, 2022. Crossref

  56. Chrysostomou Stelios, Roy Rajat, Prischi Filippo, Thamlikitkul Lucksamon, Chapman Kathryn L., Mufti Uwais, Peach Robert, Ding Laifeng, Hancock David, Moore Christopher, Molina-Arcas Miriam, Mauri Francesco, Pinato David J., Abrahams Joel M., Ottaviani Silvia, Castellano Leandro, Giamas Georgios, Pascoe Jennifer, Moonamale Devmini, Pirrie Sarah, Gaunt Claire, Billingham Lucinda, Steven Neil M., Cullen Michael, Hrouda David, Winkler Mathias, Post John, Cohen Philip, Salpeter Seth J., Bar Vered, Zundelevich Adi, Golan Shay, Leibovici Dan, Lara Romain, Klug David R., Yaliraki Sophia N., Barahona Mauricio, Wang Yulan, Downward Julian, Skehel J. Mark, Ali Maruf M.U., Seckl Michael J., Pardo Olivier E., Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer, Science Translational Medicine, 13, 602, 2021. Crossref

  57. Gautam Anurag Kumar, Kumar Pranesh, Raj Ritu, Kumar Dinesh, Bhattacharya Bolay, Rajinikanth P.S., Chidambaram Kumarappan, Mahata Tarun, Maity Biswanath, Saha Sudipta, Preclinical Evaluation of Dimethyl Itaconate Against Hepatocellular Carcinoma via Activation of the e/iNOS-Mediated NF-κB–Dependent Apoptotic Pathway, Frontiers in Pharmacology, 12, 2022. Crossref

  58. Giovanini Guilherme, Barros Luciana R. C., Gama Leonardo R., Tortelli Tharcisio C., Ramos Alexandre F., A Stochastic Binary Model for the Regulation of Gene Expression to Investigate Responses to Gene Therapy, Cancers, 14, 3, 2022. Crossref

  59. Bonavida Benjamin, Crosstalks between Yin-Yang 1 (YY1) and autophagy in cancer, in Autophagy in Immune Response: Impact on Cancer Immunotherapy, 2020. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain